Eyetech Pharmaceuticals Inc entered the industry of Research and Development Laboratories in 0 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 541712, which describes it as a Research and Development Laboratories. For further clarification, the SIC classifies this business under the code 8731 and described it as a Research and Development Laboratories. The business provides service to the B2B market.
To acquire more information, please contact Anthony Adamis by calling (781) 938-3937 during business hours. You can also write to the business’ Branch at 35 Hartwell Avenue, Lexington, Massachusetts MA 02421. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Eyetech Pharmaceuticals Inc |
| Representative: | Anthony Adamis |
| Place of Business: | 35 Hartwell Avenue, Lexington, MA 02421 |
| Contact Number: | (781) 938-3937 |
| Type of Service: | Research and Development Laboratories |
| SIC Number: | 8731 |
| NAICS Number: | 541712 |
| Locality: | Branch |
| Market Type: | B2B (Business to Business) |
| Income/Year: | Unknown |
| Laborers: | 1 to 4 |
| Share This Company: |
Eyetech Pharmaceuticals Inc is a company operating from Middlesex, Massachusetts providing professional Research and Development Laboratories and relevant B2B variables. It was founded in 0 and registered with the SIC code 8731 as Research and Development Laboratories, and with the NAICS code 541712 as Research and Development Laboratories.
With a current employee count of 1 to 4, Eyetech Pharmaceuticals Inc has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative Anthony Adamis at (781) 938-3937 for related queries, or to locate its Branch using the coordinates .
The Branch can also be found at the street address 35 Hartwell Avenue in Lexington, Massachusetts 02421 and can be engaged online through the company website at , the company Twitter , and Facebook page .